NERV — Minerva Neurosciences Share News
0.000.00%
Last trade - 00:00Brief: Minerva Neurosciences Q3 Net Income USD 22.513 Million
Minerva Neurosciences Inc expected to post a loss of $1.01 a share - Earnings Preview
Minerva Neurosciences Inc reports results for the quarter ended in January - Earnings Summary
Brief: Minerva Neurosciences Q2 Net Income USD -8.233 Million
Minerva Neurosciences Inc expected to post a loss of 97 cents a share - Earnings Preview
Minerva Neurosciences Inc expected to post a loss of 97 cents a share - Earnings Preview
Brief: Minerva Neurosciences Q1 Net Income USD -8.569 Million
Brief: Minerva Neurosciences Gets Nasdaq Notice On Non-Compliance With Listing Rule
U.S. STOCKS ON THE MOVE-Cava, Bank of America, Fractyl Health
U.S. STOCKS ON THE MOVE-Kroger, Sezzle, Sealed Air Corp
U.S. STOCKS ON THE MOVE-Intuitive Machines, Hims & Hers Health, Macy's
Minerva Neurosciences slumps as FDA declines to approve schizophrenia drug
US FDA declines to approve Minerva Neurosciences' schizophrenia drug (updated)
US FDA declines to approve Minerva Neurosciences' schizophrenia drug
Brief: Minerva Neurosciences Receives Complete Response Letter From FDA
Brief: Minerva Neurosciences Q4 Net Income USD -9.022 Million
Brief: Minerva Neurosciences Cash Equivalents And Restricted Cash At Sept. 30, 2023, Were About $47.0 Million
Brief: Minerva Neurosciences - Cash, Cash Equivalents And Restricted Cash At September 30, 2023, Were Approximately $47.0 Million
Brief: Minerva Neurosciences Q3 Net Income USD -7.82 Million